BioDiscovery

The NxClinical software integrates copy number, sequence variant, and allelic change information obtained from microarray and NGS technologies.

The companies will develop an assay and software package for Thermo's cancer research product portfolio.

The deal covers BioDiscovery's products, including the NxClinical 4.0 software system for genomic variant analysis and interpretation.

The companies will join their respective technologies to offer customers a single solution for next-generation sequencing data interpretation.

The software allows researchers to visualize copy number variation, absence of heterozygosity, and single nucleotide variations.

The deal provides customers a complete end-to-end solution for cytogenomic array and next-generation sequencing services, the firms said.

NEW YORK (GenomeWeb) –Life science software firm BioDiscovery this week unveiled NXClinical, a new addition to its product portfolio that's tailored specifically for the clinical laboratory market and provides tools for analyzing, processing, and reporting the results of genetic tests.

NEW YORK (GenomeWeb) – Genomic analysis software maker BioDiscovery said today it will use a $157,000 grant from the National Cancer Institute to analyze and improve copy number variant data from The Cancer Genome Atlas program.

Innopsys has launched its newest microarray scanner, the InnoScan 910 microarray scanner. The two-color fluorescence scanner is capable of reading high-density microarrays with a resolution of 1 micron per pixel.

NantHealth said this week that it has launched a fully integrated genomic and transcriptomic analytic engine that can identify mutations such as copy number variants and genomic rearrangements in DNA, RNA, and protein pathways accurately and efficiently.

Pages

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.